Apollo Endosur…
ProfileJobs (7)

Apollo Endosurgery

Suggest Edit
    • Healthcaremedical devices
    Apollo Endosurgery was founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.) Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled in 1998 (Timeline) with the goal to advance the new discipline; their specific focus was the use of long, flexible instruments deployed through a natural orifice in order to diagnose and potentially treat gastrointestinal disorders.
    Revenue(FY, 2017)
    $64.3 M
    Total Funding
    $186.8 M
    TypePrivate
    HQAustin, US
    Founded2006
    Size (employees)273 (est)+3%
    Websiteapolloendo.com
    Apollo Endosurgery was founded in 2006 and is headquartered in Austin, US
    Report incorrect company information

    Viewing summary data as a guest

    Sign up for free to see all data

    Key People/Management at Apollo Endosurgery

    Todd Newton

    Todd Newton

    CEO
    Stefanie Cavanaugh

    Stefanie Cavanaugh

    CFO
    Christopher J. Gostout

    Christopher J. Gostout

    Chief Medical Officer
    Bret Schwartzhoff

    Bret Schwartzhoff

    Vice President, US Sales and Global Marketing
    Mike Gutteridge

    Mike Gutteridge

    Vice President, International Sales and Marketing
    Laura LeBoeuf

    Laura LeBoeuf

    Vice President, Quality, Regulatory, and Clinical Affairs
    Show more

    Apollo Endosurgery Office Locations

    Apollo Endosurgery has an office in Austin
    Austin, US (HQ)
    300 1120 S Capital of Texas Hwy
    Show all (1)
    Report incorrect company information

    Apollo Endosurgery Financials and Metrics

    Summary Metrics

    Founding Date

    		2006

    Apollo Endosurgery total Funding

    		$186.8 m

    Apollo Endosurgery latest funding size

    		$22 m

    Time since last funding

    		3 years ago

    Apollo Endosurgery investors

    		HIG Capital, UT Horizon Fund
    Apollo Endosurgery's latest funding round in November 2015 was reported to be $22 m. In total, Apollo Endosurgery has raised $186.8 m
    Show all financial metrics

    Apollo Endosurgery Revenue

    Embed Graph
    Apollo Endosurgery's revenue was reported to be $64.31 m in FY, 2017
    USD

    Revenue (Q2, 2018)

    		31.5m

    Gross profit (Q2, 2018)

    		18.4m

    Gross profit margin (Q2, 2018), %

    		58.3%

    Net income (Q2, 2018)

    		(17.7m)

    EBIT (Q2, 2018)

    		(15.1m)

    Cash (30-Jun-2018)

    		34.4m
    Annual
    USDFY, 2016FY, 2017

    Revenue

    		64.9m64.3m

    Cost of goods sold

    		25.3m24.6m

    Gross profit

    		39.6m39.7m

    Gross profit Margin, %

    		61%62%
    Quarterly
    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

    Revenue

    		1.3m1.1m783.9k747.6k61.3k9.6k9.2k23.8k14.6m15.7m31.5m

    Cost of goods sold

    		5.1m6.6m13.2m

    Gross profit

    		9.5m9.2m18.4m

    Gross profit Margin, %

    		65%58%58%
    show all
    Annual
    USDFY, 2016FY, 2017

    Cash

    		19.1m30.5m

    Accounts Receivable

    		10.5m

    Inventories

    		12.2m14.3m

    Current Assets

    		43.6m57.6m
    Quarterly
    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2018

    Cash

    		14.3m20.5m12.7m11.9m11.6m7.0m4.7m3.3m8.3m34.4m

    Accounts Receivable

    		1.3m2.1m1.4m731.9k56.0k9.6k9.2k24.9k

    Inventories

    		11.7m15.0m

    Current Assets

    		16.0m24.2m14.5m12.9m11.8m7.3m5.3m4.0m32.1m62.1m
    show all
    Annual
    USDFY, 2016FY, 2017

    Net Income

    		(41.2m)(27.3m)

    Depreciation and Amortization

    		7.2m9.7m

    Inventories

    		(3.1m)(2.8m)

    Accounts Payable

    		523.0k4.7m
    Quarterly
    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

    Net Income

    		(3.7m)(3.2m)(2.8m)(2.6m)(2.2m)(1.9m)(2.7m)(3.7m)(8.2m)(8.1m)(17.7m)

    Depreciation and Amortization

    		1.8m2.4m4.7m

    Inventories

    		(1.2m)(1.0m)

    Accounts Payable

    		2.5m2.6m2.0m1.7m1.2m431.1k462.7k894.6k6.4m272.0k(3.7m)
    show all
    USDY, 2018

    Revenue/Employee

    		128.9k

    Financial Leverage

    		2 x
    Show all financial metrics
    Report incorrect company information

    Competitors

    Repro Med Systems
    Healthcare - Public
    SynergEyes
    Healthcare - Private
    Apollo Medical Holdings
    Healthcare - Private
    Liberator Medical Supply
    Healthcare - Subsidiary
    Compare competitors

    Apollo Endosurgery Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Apollo Endosurgery News and Updates

    September 26, 2018

    Global Intragastric Balloons Market 2018-2022 - Key Vendors are Allurion Technologies, Apollo Endosurgery, Helioscopie, Obalon Therapeutics, ReShape Lifesciences & Spatz FGIA

    DUBLIN, Sept. 26, 2018 /PRNewswire/ -- The "Global Intragastric Balloons Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global Intragastric Balloons Market to grow at a CAGR of 25.18% during the period 2018-2022. The report has been prepared based on an...
    June 26, 2018

    Apollo Endosurgery Makes Good Progress

    Report incorrect company information

    Apollo Endosurgery Blogs

    October 09, 2018

    Apollo Endosurgery Announces Distribution Agreement with Slater Endoscopy for the Ensizor® Flexible Endoscopic Scissors

    Dateline City: AUSTIN, Texas AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced toda…
    October 01, 2018

    Apollo Endosurgery Completes Enrollment for the ORBERA Post Approval Study

    Dateline City: AUSTIN, Texas AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announce…
    September 24, 2018

    Apollo Endosurgery and Istituto Clinico Humanitas in Milano, Italy Establish European Registry for Flexible Endoscopic Suturing Procedures in Gastrointestinal Applications

    Dateline City: AUSTIN, Texas AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced toda…
    September 19, 2018

    Apollo Endosurgery August 2018 Presentation

    File: APEN_Aug_2018_Presentation.pdf (1.89 MB) Related Materials Webcast Presentation Language: English
    August 08, 2018

    Latest Earnings Release

    File: Apollo Endosurgery, Inc. Reports Second Quarter 2018 Results (370.77 KB) Language: English
    August 08, 2018

    10-Q Quarterly Report

    File: Apollo Endosurgery, Inc Form 10-Q for the quarterly period ended June 30, 2018 (722.41 KB) Language: English
    Show more

    Apollo Endosurgery Company Life and Culture

    Report incorrect company information
    Download PDF